While many DEXs are still struggling with the slippage and liquidity of AMMs, Injective has built a brand new pathway for decentralized trading.
As a veteran in the crypto space, I have witnessed the transformation of the DEX world from chaos to prosperity. Today, what Injective brings is not just a simple iteration, but a complete reconstruction of the underlying logic. Unlike traditional AMM models (such as Uniswap) or RFQ models, the fundamental difference with Injective is that it has created a high-performance public chain specifically tailored for order book trading. This is not just a technical upgrade, but a thorough revolution in trading experience.
Beyond the on-chain order books of AMMs and RFQs
Although AMM DEXs like Uniswap have promoted the popularization of DeFi, issues such as inherent liquidity fragmentation and high slippage continue to plague professional traders. While the RFQ model improves capital turnover, it falls short of AMM in terms of composability in the early days of DeFi. Injective has chosen a different path—an on-chain order book. Leveraging the high-performance advantages of the Cosmos underlying infrastructure, it achieves near-instant trade finality and low-latency matching, allowing the order book trading experience in a decentralized environment to rival that of centralized platforms for the first time.
MultiVM Architecture: Connecting the Duodenum of the Developer Ecosystem
Recently, Injective launched its native EVM, marking a key breakthrough. This means that Solidity developers can now 'copy and paste' their code and deploy it directly on Injective. At the same time, Injective has not abandoned its original CosmWasm environment but has innovatively implemented a MultiVM dual-architecture in parallel, allowing applications and data from both ecosystems to interoperate. Currently, more than 40 dApps and infrastructure providers are prepared to deploy here, ushering in a new era of on-chain finance.
Institutional Recognition: From Digital Asset Treasury to ETF Progress
Market recognition speaks volumes. The listed company Pineapple Financial has established a $100 million digital asset treasury for INJ and has purchased a large amount of INJ tokens through the open market. Even more excitingly, 21Shares has submitted an INJ spot ETF application to the U.S. SEC. This not only means that ordinary investors will have access to INJ through Wall Street channels but also reflects the high recognition of Injective's technological value by institutions.
While unified DEXs continue to struggle in homogeneous competition, Injective has outlined new possibilities for decentralized trading through a customized public chain, MultiVM architecture, and institutional-level channels. This is not just a technological upgrade but a fundamental shift in the entire DEX paradigm.
Dear cryptocurrency friends, do you prefer the traditional AMM or Injective's order book model? Feel free to share your views in the comments!
